Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Skin can become dry and thick in hypothyroidism.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Covid-19 can cause hair loss due to immune and psychological factors.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Experts agree on the need for standardized definitions and education for post-COVID-19 conditions.

Lower LDL-c levels predict higher COVID-19 mortality.

During the COVID-19 pandemic, some skin conditions became more common while others decreased.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

People in Jeddah know about Vitamin D and its sources but are unclear on how much they need daily, and while many women take supplements, attitudes towards increasing Vitamin D levels vary.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

University students in Egypt experienced high stress during COVID-19's third wave, with negative coping mechanisms being more common.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

Robotic hair transplantation with AI offers more reliable, precise, and efficient hair restoration.

Shi-Bi-Man activates hair follicle stem cells and promotes hair growth by changing lactic acid metabolism and other cellular processes.

No single biomarker is reliable enough for diagnosing and assessing SLE.